The mission of the RT/EC is to eliminate health disparities in the Inland Empire and nationally through the research training and education of the next generation of health disparities researchers. To accomplish this mission we have initiated a comprehensive pipeline of health disparities research trainees at various levels in their academic development (from high school to junior faculty) that is unique and innovative in the Inland Empire in its scope and focus. A flow chart describing this pipeline (Figure 1.3) is presented above in section I- Narrative Overview of the Proposed NIMHD COE. LLU-CHDMM has the resources, the experience, and the vision to contribute to the development of future leaders in biomedical research and medicine who will be well-prepared and highly motivated to eliminate health disparities. The PI and his colleagues have an extensive track record in establishing research training and education programs targeted to students from underrepresented and health disparities populations. Renewed NIMHD funding will help us realize our vision to continue widening and strengthening the fragile pipeline of underrepresented students preparing to become biomedical researchers and doctors in service to their communities and their country. The impact of combining our individual and institutional commitment with NIH grant support will be: 1) desired measurable outcomes within the Inland Empire;2) a model for eliminating health disparities through research training and education;3) a comprehensive pipeline that will bring a diversity of fresh ideas to advance the biomedical sciences;and 4) expansion of health knowledge in the student's own communities, resulting in healthier lifestyle practices.

Agency
National Institute of Health (NIH)
Institute
National Institute on Minority Health and Health Disparities (NIMHD)
Type
Exploratory Grants (P20)
Project #
5P20MD006988-02
Application #
8485672
Study Section
Special Emphasis Panel (ZMD1-RN)
Project Start
Project End
Budget Start
2013-02-01
Budget End
2014-01-31
Support Year
2
Fiscal Year
2013
Total Cost
$104,996
Indirect Cost
$38,602
Name
Loma Linda University
Department
Type
DUNS #
009656273
City
Loma Linda
State
CA
Country
United States
Zip Code
92350
Liu, Jo-Wen; Montero, Manuel; Bu, Liming et al. (2015) Epidermal fatty acid-binding protein protects nerve growth factor-differentiated PC12 cells from lipotoxic injury. J Neurochem 132:85-98
Spencer-Hwang, Rhonda; Montgomery, Susanne; Dougherty, Molly et al. (2014) Experiences of a rail yard community: life is hard. J Environ Health 77:8-17
Payne, Kimberly J; Dovat, Sinisa (2014) G0S2--a new player in leukemia. Leuk Res 38:147-8
Salto, Lorena M; Riggs, Matt L; Delgado De Leon, Daisy et al. (2014) Underrepresented minority high school and college students report STEM-pipeline sustaining gains after participating in the Loma Linda University Summer Health Disparities Research Program. PLoS One 9:e108497
Weldon, David J; Saulsbury, Marilyn D; Goh, Joshua et al. (2014) One-pot synthesis of cinnamylideneacetophenones and their in vitro cytotoxicity in breast cancer cells. Bioorg Med Chem Lett 24:3381-4
Pacheco, Fabio J; Almaguel, Frankis G; Evans, Whitney et al. (2014) Docosahexanoic acid antagonizes TNF-?-induced necroptosis by attenuating oxidative stress, ceramide production, lysosomal dysfunction, and autophagic features. Inflamm Res 63:859-71
Salud, Margaret C; Marshak, Helen Hopp; Natto, Zuhair S et al. (2014) Exploring HIV-testing intentions in young Asian/Pacific Islander (API) women as it relates to acculturation, theory of gender and power (TGP), and the AIDS risk reduction model (ARRM). AIDS Care 26:642-7
Galloway, Nicholas R; Diaz Osterman, Carlos J; Reiber, Karl et al. (2014) Yin Yang 1 regulates the transcriptional repression of Survivin. Biochem Biophys Res Commun 445:208-13
Figueroa, Johnny D; De Leon, Marino (2014) Neurorestorative targets of dietary long-chain omega-3 fatty acids in neurological injury. Mol Neurobiol 50:197-213
Dai, Liping; Li, Jitian; Ortega, Rosalia et al. (2014) Preferential autoimmune response in prostate cancer to cyclin B1 in a panel of tumor-associated antigens. J Immunol Res 2014:827827

Showing the most recent 10 out of 14 publications